Back to Results

Copeptin and Nonalcoholic Fatty Liver Disease

Study category: Diabetes & Hormone Disorders

Is this Study for You?

Let's Get Started!

Description

See above

Details
Age

Adult

Eligibility

Obese 30-40 BMI, age 30-75

Diabetes, other liver disease or eGFR<45.

Type of Study

Observational

Locations

Anschutz Health and Wellness
Outpatient CTRC
UCD Anschutz Health & Wellness Center
University of Colorado Hospital

Principal Investigator
Thomas Jensen,  MD

Thomas Jensen, MD

Study ID

Protocol Number: 17-1160

More information available at ClinicalTrials.gov: NCT03254563

Is this Study for You?

Let's Get Started!

Not finding the right Study for you? Join ResearchMatch, a nation-wide registry connecting volunteers and researchers